Nature's carriers: leveraging extracellular vesicles for targeted drug delivery

Qi Chen Yuyi Zheng Xuhong Jiang Yi Wang Zhong Chen Di Wu a Interdisciplinary Institute for Medical Engineering,Fuzhou University,Fuzhou,P. R. Chinab Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province,School of Pharmaceutical Sciences,Zhejiang Chinese Medical University,Hangzhou,Chinac Epilepsy Center,Department of Neurology,The First Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou,PR Chinad Zhejiang Rehabilitation Medical Center,The Third Affiliated Hospital of Zhejiang,Chinese Medical University,Hangzhou,PR China
DOI: https://doi.org/10.1080/10717544.2024.2361165
IF: 6.819
2024-06-04
Drug Delivery
Abstract:With the rapid development of drug delivery systems, extracellular vesicles (EVs) have emerged as promising stars for improving targeting abilities and realizing effective delivery. Numerous studies have shown when compared to conventional strategies in targeted drug delivery (TDD), EVs-based strategies have several distinguished advantages besides targeting, such as participating in cell-to-cell communications and immune response, showing high biocompatibility and stability, penetrating through biological barriers, etc. In this review, we mainly focus on the mass production of EVs including the challenges and strategies for scaling up EVs production in a cost-effective and reproducible manner, the loading and active targeting methods, and examples of EVs as vehicles for TDD in consideration of potential safety and regulatory issues associated. We also conclude and discuss the rigor and reproducibility of EVs production, the current research status of the application of EVs-based strategies to targeted drug delivery, clinical conversion prospects, and existing chances and challenges.
pharmacology & pharmacy
What problem does this paper attempt to address?
### What problems does this paper attempt to solve? This paper mainly explores how to use extracellular vesicles (EVs) as carriers for targeted drug delivery and has solved the following key problems: 1. **Enhancing the targeting ability of drug delivery**: - The paper emphasizes the unique advantages of EVs in drug delivery, such as participating in inter - cellular communication, immune response, high biocompatibility and stability, and being able to penetrate biological barriers. Compared with traditional drug delivery methods, EVs have higher targeting and specificity, which can reduce the side effects of drugs on non - target cells. 2. **Technical challenges in large - scale production of EVs**: - The paper discusses in detail the challenges and strategies faced by the large - scale production of EVs, including problems in separation, purification, quality control, storage, and transportation. Currently, the low yield of EVs has become a major limiting factor for its clinical application. Therefore, studying how to efficiently and cost - effectively produce high - quality EVs on a large scale is one of the key problems in this field. 3. **Methods of drug loading and active targeting**: - The paper introduces three different EVs modification strategies: pre - modification, per - modification, and post - modification. These strategies aim to optimize the drug - loading capacity and targeting performance of EVs to achieve more effective drug delivery. 4. **The application prospects of EVs in targeted drug delivery**: - The paper summarizes the current research status of EVs in targeted drug delivery, discusses the prospects of its clinical transformation, as well as the existing opportunities and challenges. The author points out that although EVs have great potential in drug delivery, further research on their safety and regulatory issues is still required to ensure their feasibility and effectiveness in clinical applications. By solving these problems, the paper aims to promote the further development of EVs in the field of drug delivery and provide new ideas and technical means for future treatments. ### Formula example When discussing the physical properties of EVs, some formulas may be involved, such as the formula for describing the size distribution of EVs: \[ D=\frac{C}{\sqrt{\pi N}} \] where: - \( D \) represents the average diameter - \( C \) is a constant - \( N \) is the number of particles Note that the specific formula will vary according to the actual application scenario, and the above formula is only an example.